These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3296960)

  • 1. [Clinical significance of serum DU-PAN-2 surveyed by solid-phase sandwich EIA for DU-PAN-2].
    Ishii M; Urabe T; Seino Y
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1860-5. PubMed ID: 3296960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of serum DU-PAN-2 by enzyme immunoassay in patients with various digestive cancers].
    Takemori Y; Sawabu N; Satomura Y; Ohta H; Watanabe H; Okai T; Mai M; Hattori N; Akiyama T; Hashimoto T
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):119-26. PubMed ID: 3541791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of DU-PAN-2 antigen (pancreatic cancer-associated antigen) in sera of patients with cancer of the digestive tract].
    Takami H; Furuuchi T; Ogata Y; Abe O
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3207-14. PubMed ID: 3777958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical investigation of carbohydrate antigen CA-50].
    Ishii M; Abe O; Okura H; Okazaki N; Kawai T; Saito Y; Sawabu N; Takamizawa Y; Takeuchi T; Niitani H
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2548-55. PubMed ID: 3304170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlative study on expression of CA 19-9 and DU-PAN-2 in tumor tissue and in serum of pancreatic cancer patients.
    Takasaki H; Uchida E; Tempero MA; Burnett DA; Metzgar RS; Pour PM
    Cancer Res; 1988 Mar; 48(6):1435-8. PubMed ID: 3162196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic usefulness and limitation of measuring pancreatic cancer associate antigen, SPan-1, in patients with pancreatic cancer].
    Satake K; Chung YS; Umeyama K; Takeuchi T; Kim YS
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1139-46. PubMed ID: 2730018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression of CA 19-9, DU-PAN-2, CA 125, and TAG-72 in pancreatic adenocarcinoma.
    Tempero M; Takasaki H; Uchida E; Takiyama Y; Colcher D; Metzgar RS; Pour PM
    Am J Surg Pathol; 1989; 13 Suppl 1():89-95. PubMed ID: 2699170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pancreatic oncofetal antigen (POA): its characterization and application for enzyme immunoassay.
    Oguchi H; Homma T; Kawa S; Nagata A; Furuta S; Fukui H
    Cancer Detect Prev; 1984; 7(1):51-8. PubMed ID: 6367984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sandwich enzyme immunoassay of an adenocarcinoma-associated antigen, YH206, in cancer sera.
    Hinoda Y; Imai K; Ban T; Endo T; Yachi A
    Jpn J Cancer Res; 1987 Jun; 78(6):607-13. PubMed ID: 3038813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies.
    Metzgar RS; Gaillard MT; Levine SJ; Tuck FL; Bossen EH; Borowitz MJ
    Cancer Res; 1982 Feb; 42(2):601-8. PubMed ID: 7034925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies against human pancreatic adenocarcinoma: distribution of DU-PAN-2 antigen on glandular epithelia and adenocarcinomas.
    Borowitz MJ; Tuck FL; Sindelar WF; Fernsten PD; Metzgar RS
    J Natl Cancer Inst; 1984 May; 72(5):999-1005. PubMed ID: 6371347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lewis and secretor gene dosages affect CA19-9 and DU-PAN-2 serum levels in normal individuals and colorectal cancer patients.
    Narimatsu H; Iwasaki H; Nakayama F; Ikehara Y; Kudo T; Nishihara S; Sugano K; Okura H; Fujita S; Hirohashi S
    Cancer Res; 1998 Feb; 58(3):512-8. PubMed ID: 9458099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and properties of a human pancreatic adenocarcinoma-associated antigen, DU-PAN-2.
    Lan MS; Finn OJ; Fernsten PD; Metzgar RS
    Cancer Res; 1985 Jan; 45(1):305-10. PubMed ID: 3965141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A basic and clinical study of CA 19-9-MP-Mitsui kit for determination of CA 19-9].
    Ishii M; Iida M; Seino Y
    Gan To Kagaku Ryoho; 1994 Dec; 21(16):2779-86. PubMed ID: 7993114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of tumor-associated antigen of the digestive tract by monoclonal antibody].
    Imai K; Hinoda Y; Yachi A
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2185-90. PubMed ID: 3606145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation on an enzyme immunoassay kit for basic fetoprotein (BFP). (1) Clinical usefulness of BFP].
    Ishii M; Hattori N; Kato T; Mochizuki M; Kamidono S; Sawabu N; Kawada Y; Kawai T; Abe O; Ohkura H
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2107-13. PubMed ID: 2456039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of the NCC-ST-439 EIA kit using serum from patients with various types of cancer and benign disease (1)].
    Ohkura H; Hattori N; Miyazaki I; Sawabu N; Tobe R; Kawai K; Abe O; Ishii M; Kawai T; Kamano T
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1901-6. PubMed ID: 2439020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of lung adenocarcinoma-associated antigens in human tissues and sera defined by monoclonal antibodies KM-52 and KM-93.
    Shitara K; Hanai N; Yoshida H
    Cancer Res; 1987 Mar; 47(5):1267-72. PubMed ID: 3545444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies].
    Gang Y; Adachi I; Ohkura H; Yamamoto H; Mizuguchi Y; Abe K
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2379-86. PubMed ID: 3865634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor markers of pancreatic cancer].
    Takami H; Hishinuma S; Shintoku J; Furuuchi T; Ogata Y; Abe O
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):212-9. PubMed ID: 3855615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.